Gastroenterology in Aiken, SC
3 verified gastroenterology doctors in Aiken.
Gastroenterologists specialize in the digestive system, treating conditions of the stomach, intestines, liver, and pancreas.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the South Carolina Board of Medical Examiners
Dr. Afsar Waraich, MD
Gastroenterology
CMS Open Payments· $646.18 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$646.18
Total received
39
Transactions
12
Paying companies
Top paying companies
Among the 17,272 gastroenterology doctors we've analyzed, about 63% received any industry payment (median $623 among those who did). This doctor's total ranks around the 69th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US gastroenterology doctors.
Payments to Afsar Waraich do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ayaz Chaudhary, MD
Gastroenterology
CMS Open Payments· $425.23 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$425.23
Total received
16
Transactions
7
Paying companies
Top paying companies
Among the 17,272 gastroenterology doctors we've analyzed, about 63% received any industry payment (median $623 among those who did). This doctor's total ranks around the 63th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US gastroenterology doctors.
Payments to Ayaz Chaudhary do not imply any wrongdoing. Many are meals, education, or research support.
Dr. David Keisler, MD
Gastroenterology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.